Product Information
CANDESARTAN CILEXETIL 32 MG TB is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.5392 per EA under NDC 00378323293. Its NADAC has been published 329 times since Mar 11, 2020.
Strength
32 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378323293
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CANDESARTAN CILEXETILApproval Type
Generic (ANDA)
FDA Application
ANDA078702On Market Since
1/6/2020
Pharmacological Classes
Price Statistics
The NADAC for CANDESARTAN CILEXETIL 32 MG TB has been published 329 times since Mar 11, 2020, and over the history we have for it it has declined 62.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5392 per EA |
|---|---|
| All-time high | $1.4516 (May 13, 2020) |
| All-time low | $0.5392 (Jun 17, 2026) |
| 52-week high | $0.7013 |
| 52-week low | $0.5392 |
| Median price | $1.0014 |
| Average price | $0.9564 |
| Largest weekly change | -34.5% (Nov 20, 2024) |
| Weeks tracked | 329 |
| Tracking since | Mar 11, 2020 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CANDESARTAN CILEXETIL 32 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for CANDESARTAN CILEXETIL 32 MG TB, manufactured by Mylan Pharmaceuticals Inc., is $0.5392 per EA (NDC 00378323293), effective Jun 24, 2026.
How has the price of CANDESARTAN CILEXETIL 32 MG TB changed over time?
Over the history we have for it, the NADAC for CANDESARTAN CILEXETIL 32 MG TB has declined 62.6%. It has been tracked across 329 weekly CMS publications since Mar 11, 2020.
What are the highest and lowest recorded NADAC prices for CANDESARTAN CILEXETIL 32 MG TB?
Since Mar 11, 2020, the NADAC for CANDESARTAN CILEXETIL 32 MG TB has ranged from a low of $0.5392 (Jun 17, 2026) to a high of $1.4516 (May 13, 2020), with a median of $1.0014 per EA.
Are there cheaper alternatives to CANDESARTAN CILEXETIL 32 MG TB?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as CANDESARTAN CILEXETIL 32 MG TB, but none are currently priced below it.
Who manufactures CANDESARTAN CILEXETIL 32 MG TB?
CANDESARTAN CILEXETIL 32 MG TB (NDC 00378323293) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification